MaxCyte provided its platform technology to Anocca AB, which will use the technology for manufacturing.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MaxCyte provided its platform technology to Anocca AB, which will use the technology for manufacturing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MaxCyte (United States)
Biotech company in Rockville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireMaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the ma